复旦肿瘤医院团队方案使三阴性乳腺癌患者5年无病生存率大大提高 - 2020年08月18日

A chemotherapy program developed by local medical experts has improved the five-year disease-free survival rate of patients with one challenging form of breast cancer.
This is the first research breakthrough of its kind led by Chinese doctors, said experts from the Shanghai Cancer Center on Monday.
Breast cancer is the most common form of cancer among women. Among all types of breast cancer, the so called "triple-negative" variety is the toughest to treat, as it does not express genes for estrogen receptors, progesterone receptors or HER2. With no targeted therapy, chemotherapy is the only treatment option.